{"id":1689,"date":"2022-02-10T16:06:53","date_gmt":"2022-02-10T16:06:53","guid":{"rendered":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/?p=1689"},"modified":"2023-10-24T12:46:03","modified_gmt":"2023-10-24T15:46:03","slug":"grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3","status":"publish","type":"post","link":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/","title":{"rendered":"Grupos de risco: nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3"},"content":{"rendered":"<p>A <a href=\"https:\/\/www.fresenius-kabi.com\/br\/produtos\/nutricao-parenteral\">nutri\u00e7\u00e3o parenteral (NP<\/a>) \u00e9 indicada a todos os pacientes que estejam desnutridos ou em fase de desnutri\u00e7\u00e3o. Em geral, essas pessoas n\u00e3o podem ser alimentadas por via oral ou, ainda, apresentam um trato gastrointestinal (GI) n\u00e3o funcionante, inacess\u00edvel ou lesionado<a class=\"bibliography-sup\" title=\"KABI, F. Comp\u00eandio de Nutri\u00e7\u00e3o Parenteral: 2018. P. 26; FRESENIUS KABI. Dispon\u00edvel em: https:\/\/www.fresenius-kabi.com\/br\/documents\/compendio_10_05_2018.pdf 1. RUSSEL F.D., MEITAL L.T. (2018) Health Impacts of Omega-3 Fatty Acid Deficiency. In: Preedy V., Patel V. (eds) Handbook of Famine, Starvation, and Nutrient Deprivation. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-40007-5_110-1 \" href=\"#\" data-bibliography-link=\"\">1<\/a>.<\/p>\n<p>Outras condi\u00e7\u00f5es que podem requerer o uso de NP s\u00e3o:<\/p>\n<ul>\n<li>Doen\u00e7as cr\u00edticas<\/li>\n<li>P\u00f3s-cir\u00fargico<\/li>\n<li>Complementa\u00e7\u00e3o de nutri\u00e7\u00e3o enteral (NE)<\/li>\n<\/ul>\n<p>Entre os nutrientes que podem ser fornecidos por meio da nutri\u00e7\u00e3o parenteral est\u00e3o os lip\u00eddios. Viabilizados por emuls\u00f5es lip\u00eddicas (EL) que cont\u00eam \u00e1cidos graxos essenciais, como \u00e9 o caso do \u00f4mega 3 (\u03c93), os lip\u00eddios s\u00e3o caracterizados por sua alta energia e baixo teor de \u00e1gua.<\/p>\n<h2>Nutri\u00e7\u00e3o parenteral com \u00f4mega 3 no paciente de risco<\/h2>\n<p>Um ponto importante \u00e9 relembrar que o corpo humano n\u00e3o tem capacidade de sintetizar \u00e1cidos graxos poli-insaturados<a class=\"bibliography-sup\" title=\"2. PRADELLI, L. et al; \u03c9-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review with Meta-Analysis and Trial Sequential Analysis: 2020; JPEN. P. 44-57. Dispon\u00edvel em: https:\/\/pubmed.ncbi.nlm.nih.gov\/31250474\/ \" href=\"#\" data-bibliography-link=\"\">2<\/a>, como \u00e9 o caso do \u00f4mega 3. Sendo assim, sua forma de obten\u00e7\u00e3o ocorre por meio da dieta, sobretudo aquelas com consumo suficiente de peixes. Logo, quando o paciente se encontra em situa\u00e7\u00e3o de restri\u00e7\u00e3o alimentar, o risco de deixar de consumir tais nutrientes se torna significante, levando a desfechos de defici\u00eancia de \u00f4mega 3<a class=\"bibliography-sup\" title=\"2. PRADELLI, L. et al; \u03c9-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review with Meta-Analysis and Trial Sequential Analysis: 2020; JPEN. P. 44-57. Dispon\u00edvel em: https:\/\/pubmed.ncbi.nlm.nih.gov\/31250474\/ \" href=\"#\" data-bibliography-link=\"\">\u00b2<\/a>.<\/p>\n<p>Uma <a href=\"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jpen.1672\">revis\u00e3o<\/a> de estudos publicada pelo <a href=\"https:\/\/aspenjournals.onlinelibrary.wiley.com\/journal\/19412444\">Journal of Parenteral and Enteral Nutrition (JPEN)<\/a>, investigou a nutri\u00e7\u00e3o parenteral enriquecida com \u00f4mega 3 versus o uso de nutri\u00e7\u00e3o parenteral padr\u00e3o (n\u00e3o enriquecida com \u00f4mega 3) em pacientes adultos hospitalizados<a class=\"bibliography-sup\" title=\"3. STEGINK, L.D., FREEMAN, J.B., WISPE, J., CONNOR, W.E. Absence of the biochemical symptoms of essential fatty acid deficiency in surgical patients undergoing protein sparing therapy. Am J Clin Nutr. 1977; 30(3):388\u2013393. Dispon\u00edvel em: DOI: 10.1093\/ajcn\/30.3.388\" href=\"#\" data-bibliography-link=\"\">3<\/a>. Foram analisados 49 ensaios cl\u00ednicos randomizados e os resultados mostraram que o risco relativo de infec\u00e7\u00e3o foi 40% menor em pacientes que receberam emuls\u00e3o lip\u00eddica enriquecida com \u00f4mega 3, em compara\u00e7\u00e3o com o grupo que recebeu a EL padr\u00e3o. Os pacientes que receberam NP enriquecida com \u00f4mega 3 tamb\u00e9m tiveram redu\u00e7\u00e3o do tempo de perman\u00eancia em unidade de terapia intensiva (UTI). Os resultados revelaram ainda uma redu\u00e7\u00e3o de 56% nos riscos de sepse para o grupo que recebeu EL enriquecida com w3<a class=\"bibliography-sup\" title=\"3. STEGINK, L.D., FREEMAN, J.B., WISPE, J., CONNOR, W.E. Absence of the biochemical symptoms of essential fatty acid deficiency in surgical patients undergoing protein sparing therapy. Am J Clin Nutr. 1977; 30(3):388\u2013393. Dispon\u00edvel em: DOI: 10.1093\/ajcn\/30.3.388\" href=\"#\" data-bibliography-link=\"\">3<\/a>.<\/p>\n<h3>Em que casos pode ocorrer a defici\u00eancia de \u00f4mega 3?<\/h3>\n<ul>\n<li>Em pacientes recebendo nutri\u00e7\u00e3o parenteral sem lip\u00eddios;<sup> <a class=\"bibliography-sup\" title=\"4. JEPPESEN, P.B., HOY, C.E., MORTENSEN, P.B. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr. 2000; 54(8):632\u2013642. Dispon\u00edvel em: DOI: 10.1038\/sj.ejcn.1601067\" href=\"#\" data-bibliography-link=\"\">4<\/a><\/sup><\/li>\n<li>Em pacientes com m\u00e1 absor\u00e7\u00e3o cr\u00f4nica de lip\u00eddios dos alimentos;<sup> <a class=\"bibliography-sup\" title=\"5. LEPAGE, G et al. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res. 1989; 30(10):1483\u20131490. Dispon\u00edvel em: https:\/\/www.jlr.org\/article\/S0022-2275(20)38233-X\/pdf \" href=\"#\" data-bibliography-link=\"\">5<\/a><\/sup><\/li>\n<li>Em pacientes com fibrose c\u00edstica;<sup> <a class=\"bibliography-sup\" title=\"6. UAUY, R. et all. Essential fatty acids in visual and brain development. Lipids. 2001; 36(9):885\u2013895. Dispon\u00edvel em: DOI: 10.1007\/s11745-001-0798-1\" href=\"#\" data-bibliography-link=\"\">6<\/a><\/sup><\/li>\n<li>Em beb\u00eas pr\u00e9-termo, vulner\u00e1veis aos efeitos adversos da insufici\u00eancia de DHA materna;<a class=\"bibliography-sup\" title=\"7. FEDOROVA, I. et all. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci. 2009; 123(1):196\u2013205. Dispon\u00edvel em: DOI: 10.1037\/a0013801\" href=\"#\" data-bibliography-link=\"\">7<\/a><\/li>\n<li>Em crian\u00e7as com alergias alimentares que restringem o consumo de alguns alimentos<\/li>\n<\/ul>\n<figure id=\"attachment_1721\" aria-describedby=\"caption-attachment-1721\" style=\"width: 1024px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1721 size-large\" src=\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3-1024x538.png\" alt=\"\" width=\"1024\" height=\"538\" srcset=\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3-1024x538.png 1024w, https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3-300x157.png 300w, https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3-768x403.png 768w, https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3-580x304.png 580w, https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/lam073v01jan22-omega-3.png 1301w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption id=\"caption-attachment-1721\" class=\"wp-caption-text\">Refer\u00eancias <a class=\"bibliography-sup\" style=\"font-size: 16px\" title=\"5. LEPAGE, G et al. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res. 1989; 30(10):1483\u20131490. Dispon\u00edvel em: https:\/\/www.jlr.org\/article\/S0022-2275(20)38233-X\/pdf \" href=\"#\" data-bibliography-link=\"\">5,<\/a><a class=\"bibliography-sup\" style=\"font-size: 16px\" title=\"8. FEDOROVA, I., SALEM, N. Jr. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids. 2006; 75(4-5):271\u2013289. Dispon\u00edvel em: DOI: 10.1016\/j.plefa.2006.07.006\" href=\"#\" data-bibliography-link=\"\">8,<\/a><a class=\"bibliography-sup\" style=\"font-size: 16px\" title=\"9. ENGEL, P.; Essential fatty acids: 2010. NUTRI FACTS. Dispon\u00edvel em: https:\/\/www.nutri-facts.org\/en_US\/nutrients\/items\/essential-fatty-acids\/essential-fatty-acids\/deficiency.html \" href=\"#\" data-bibliography-link=\"\">9<\/a><\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A nutri\u00e7\u00e3o parenteral (NP) \u00e9 indicada a todos os pacientes que estejam desnutridos ou em fase de desnutri\u00e7\u00e3o. Em geral, essas pessoas n\u00e3o podem ser alimentadas por via oral ou, ainda, apresentam um trato gastrointestinal (GI) n\u00e3o funcionante, inacess\u00edvel ou lesionado1. Outras condi\u00e7\u00f5es que podem requerer o uso de NP s\u00e3o: Doen\u00e7as cr\u00edticas P\u00f3s-cir\u00fargico Complementa\u00e7\u00e3o [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1718,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49,9],"tags":[],"class_list":["post-1689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artigo-5","category-nutricao-parenteral"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco<\/title>\n<meta name=\"description\" content=\"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco\" \/>\n<meta property=\"og:description\" content=\"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Unidos pela Nutri\u00e7\u00e3o Cl\u00ednica | Brasil\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-10T16:06:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-24T15:46:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"856\" \/>\n\t<meta property=\"og:image:height\" content=\"571\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"actycrea\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"actycrea\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\"},\"author\":{\"name\":\"actycrea\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/047903fcf38a9d211770ad89bfd1360b\"},\"headline\":\"Grupos de risco: nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3\",\"datePublished\":\"2022-02-10T16:06:53+00:00\",\"dateModified\":\"2023-10-24T15:46:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\"},\"wordCount\":419,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization\"},\"image\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg\",\"articleSection\":[\"Artigos\",\"Nutri\u00e7\u00e3o Parenteral\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\",\"url\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\",\"name\":\"Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco\",\"isPartOf\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg\",\"datePublished\":\"2022-02-10T16:06:53+00:00\",\"dateModified\":\"2023-10-24T15:46:03+00:00\",\"description\":\"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!\",\"breadcrumb\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage\",\"url\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg\",\"contentUrl\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg\",\"width\":856,\"height\":571},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Grupos de risco: nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#website\",\"url\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/\",\"name\":\"Unidos pela Nutri\u00e7\u00e3o Cl\u00ednica | Brasil\",\"description\":\"\u00c9 uma iniciativa criada pela Fresenius Kabi para ajudar aos profissionais de sa\u00fade.\",\"publisher\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization\",\"name\":\"Fresenius Kabi AG\",\"url\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2018\/06\/Downloads_en_0001_Logo_edit_portugues.jpg\",\"contentUrl\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2018\/06\/Downloads_en_0001_Logo_edit_portugues.jpg\",\"width\":600,\"height\":400,\"caption\":\"Fresenius Kabi AG\"},\"image\":{\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/047903fcf38a9d211770ad89bfd1360b\",\"name\":\"actycrea\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9042e27db93a614c07eb85dea83a1a24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9042e27db93a614c07eb85dea83a1a24?s=96&d=mm&r=g\",\"caption\":\"actycrea\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco","description":"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/","og_locale":"pt_BR","og_type":"article","og_title":"Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco","og_description":"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!","og_url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/","og_site_name":"Unidos pela Nutri\u00e7\u00e3o Cl\u00ednica | Brasil","article_published_time":"2022-02-10T16:06:53+00:00","article_modified_time":"2023-10-24T15:46:03+00:00","og_image":[{"width":856,"height":571,"url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg","type":"image\/jpeg"}],"author":"actycrea","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"actycrea","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#article","isPartOf":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/"},"author":{"name":"actycrea","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/047903fcf38a9d211770ad89bfd1360b"},"headline":"Grupos de risco: nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3","datePublished":"2022-02-10T16:06:53+00:00","dateModified":"2023-10-24T15:46:03+00:00","mainEntityOfPage":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/"},"wordCount":419,"commentCount":0,"publisher":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage"},"thumbnailUrl":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg","articleSection":["Artigos","Nutri\u00e7\u00e3o Parenteral"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/","url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/","name":"Nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3 em grupos de risco","isPartOf":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage"},"image":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage"},"thumbnailUrl":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg","datePublished":"2022-02-10T16:06:53+00:00","dateModified":"2023-10-24T15:46:03+00:00","description":"Pacientes incapazes de manter uma dieta rica em \u00f4mega 3 podem receber indica\u00e7\u00e3o de suplementa\u00e7\u00e3o e, em geral, obt\u00eam benef\u00edcios que v\u00e3o desde redu\u00e7\u00e3o de risco de infec\u00e7\u00f5es at\u00e9 redu\u00e7\u00e3o de dias de interna\u00e7\u00e3o. Veja mais!","breadcrumb":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#primaryimage","url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg","contentUrl":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2022\/02\/mood-gnp-5.jpeg","width":856,"height":571},{"@type":"BreadcrumbList","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/grupos-de-risco-nutricao-parenteral-e-deficiencia-de-omega-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Grupos de risco: nutri\u00e7\u00e3o parenteral e defici\u00eancia de \u00f4mega 3"}]},{"@type":"WebSite","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#website","url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/","name":"Unidos pela Nutri\u00e7\u00e3o Cl\u00ednica | Brasil","description":"\u00c9 uma iniciativa criada pela Fresenius Kabi para ajudar aos profissionais de sa\u00fade.","publisher":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#organization","name":"Fresenius Kabi AG","url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2018\/06\/Downloads_en_0001_Logo_edit_portugues.jpg","contentUrl":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-content\/uploads\/sites\/3\/2018\/06\/Downloads_en_0001_Logo_edit_portugues.jpg","width":600,"height":400,"caption":"Fresenius Kabi AG"},"image":{"@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/047903fcf38a9d211770ad89bfd1360b","name":"actycrea","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9042e27db93a614c07eb85dea83a1a24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9042e27db93a614c07eb85dea83a1a24?s=96&d=mm&r=g","caption":"actycrea"}}]}},"_links":{"self":[{"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/posts\/1689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/comments?post=1689"}],"version-history":[{"count":0,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/posts\/1689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/media\/1718"}],"wp:attachment":[{"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/media?parent=1689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/categories?post=1689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lam.unitedforclinicalnutrition.com\/pt-br\/wp-json\/wp\/v2\/tags?post=1689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}